サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：バクテリオファージの世界市場：成長、将来展望、競合分析 (2022年～2030年)
市場調査レポート
商品コード
1166612

バクテリオファージの世界市場：成長、将来展望、競合分析 (2022年～2030年)

Bacteriophage Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 116 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
バクテリオファージの世界市場：成長、将来展望、競合分析 (2022年～2030年)
出版日: 2022年08月22日
発行: Acute Market Reports
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバクテリオファージの市場規模は今後、4.5%のCAGRで成長すると予想されています。市場の主な促進要因として、抗菌剤耐性の発生率の上昇や、昨今の技術進歩によるファージへの関心増大などが挙げられます。

用途別では、食品・飲料が最大の収益シェアを占めています。バクテリオファージは、病原性細菌を標的とする環境由来の溶菌バクテリオファージを使用する自然でグリーンな方法となっています。バクテリオファージの食品への利用が始まって以来、バクテリオファージを使って、調理済み食品、新鮮な果物、乳製品、野菜に含まれる病原菌を標的にする研究が進められています。また、バクテリオファージの臨床利用が、予測期間中に最も早く成長するでしょう。診断におけるバクテリオファージの利用増加や、ファージディスプレイ技術、創薬・開発における使用の可能性が、この分野の急成長の主な要因となっています。

2020年のバクテリオファージ市場の地域別シェアは、北米が最大となりました。抗生物質耐性感染症の克服に対する強い願望、強力に確立された研究インフラ、ファージ治療の潜在的パイプラインの存在が、北米市場の主な特性です。一方、アジア太平洋地域は、世界市場の中で最も速い発展を遂げるものと思われます。

当レポートでは、世界のバクテリオファージ市場について分析し、市場の基本構造やマクロ的・ミクロ的環境要因、全体的な市場規模の動向見通し (2020年～2030年)、セグメント別 (製品別・用途別・細菌別・投与経路別) および地域別の詳細動向、主な市場促進・抑制要因、主要企業のプロファイルと成長戦略、といった情報を取りまとめてお届けいたします。

目次

第1章 序論

第2章 エグゼクティブサマリー

第3章 バクテリオファージ市場：競合分析

  • バクテリオファージ市場：主要ベンダーの市場ポジショニング
  • バクテリオファージ市場のベンダーが採用する戦略
  • 主要な業界戦略
  • 階層分析 (2021年・2030年)

第4章 バクテリオファージ市場：マクロ分析と市場力学

  • イントロダクション
  • 世界のバクテリオファージの市場規模 (単位：100万米ドル、2020年～2030年)
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進・抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析
  • ヘプタリシス分析
  • ビジネス上の重要な問題の分析：5つの根本原因の分析と関連ソリューション

第5章 バクテリオファージ市場：製品別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • dsDNAバクテリオファージ
    • ssDNAバクテリオファージ
    • ssRNAバクテリオファージ

第6章 バクテリオファージ市場：用途別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • 食品・飲料
    • ファージディスプレイ
    • ファージセラピー
    • 環境への応用
    • 獣医
    • 診断
    • 抗菌薬の創薬

第7章 バクテリオファージ市場：細菌別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • サルモネラバクテリオファージ
    • 連鎖球菌バクテリオファージ
    • 大腸菌
    • 連鎖球菌・シュードモナスバクテリオファージ

第8章 バクテリオファージ市場：投与経路別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • 局所
    • 静脈内
    • 経鼻
    • 経口・経直腸

第9章 地域分析

  • 市場概要
  • マクロ要因と市場への影響：ダッシュボード (2021年)
  • ポーターのファイブフォースモデル、地域別：ダッシュボード (2021年)
  • PESTEL要因の地域的影響：ダッシュボード (2021年)

第10章 北米のバクテリオファージ市場 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • バクテリオファージ市場：製品別 (単位：100万米ドル、2020年～2030年)
  • バクテリオファージ市場：用途別 (単位：100万米ドル、2020年～2030年)
  • バクテリオファージ市場：細菌別 (単位：100万米ドル、2020年～2030年)
  • バクテリオファージ市場：投与経路別 (単位：100万米ドル、2020年～2030年)
  • バクテリオファージ市場：地域別 (単位：100万米ドル、2020年～2030年)
    • 北米

第11章 英国・EU諸国のバクテリオファージ市場 (単位：100万米ドル、2020年～2030年)

第12章 アジア太平洋のバクテリオファージ市場 (単位：100万米ドル、2020年～2030年)

第13章 ラテンアメリカのバクテリオファージ市場 (単位：100万米ドル、2020年～2030年)

第14章 中東・アフリカのバクテリオファージ市場 (単位：100万米ドル、2020年～2030年)

第15章 企業プロファイル

  • AmpliPhi Biosciences Corporation
  • Phage Biotech Ltd.
  • EnBiotix
  • Fixed-Phage Limited
  • InnoPhage, Ltd.
  • PHERECYDES PHARMA
  • TechnoPhage SA
  • Federal State Scientific-Industrial Company MICROGEN
  • Phage Therapy Center
  • VersatileBio
図表

List of Tables

  • TABLE 1 Global Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 3 Global Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 4 Global Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 5 North America Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 6 North America Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 7 North America Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 8 North America Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 9 U.S. Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 10 U.S. Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 11 U.S. Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 12 U.S. Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 13 Canada Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 14 Canada Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 15 Canada Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 16 Canada Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 17 Rest of North America Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 18 Rest of North America Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 19 Rest of North America Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 20 Rest of North America Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 21 UK and European Union Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 22 UK and European Union Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 23 UK and European Union Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 24 UK and European Union Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 25 UK Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 26 UK Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 27 UK Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 28 UK Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 29 Germany Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 30 Germany Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 31 Germany Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 32 Germany Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 33 Spain Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 34 Spain Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 35 Spain Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 36 Spain Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 37 Italy Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 38 Italy Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 39 Italy Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 40 Italy Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 41 France Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 42 France Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 43 France Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 44 France Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 45 Rest of Europe Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 46 Rest of Europe Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 47 Rest of Europe Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 48 Rest of Europe Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 49 Asia Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 50 Asia Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 51 Asia Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 52 Asia Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 53 China Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 54 China Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 55 China Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 56 China Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 57 Japan Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 58 Japan Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 59 Japan Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 60 Japan Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 61 India Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 62 India Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 63 India Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 64 India Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 65 Australia Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 66 Australia Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 67 Australia Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 68 Australia Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 69 South Korea Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 70 South Korea Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 71 South Korea Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 72 South Korea Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 73 Latin America Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 74 Latin America Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 75 Latin America Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 76 Latin America Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 77 Brazil Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 78 Brazil Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 79 Brazil Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 80 Brazil Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 81 Mexico Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 82 Mexico Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 83 Mexico Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 84 Mexico Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 85 Rest of Latin America Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 86 Rest of Latin America Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 87 Rest of Latin America Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 88 Rest of Latin America Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 89 Middle East and Africa Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 90 Middle East and Africa Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 91 Middle East and Africa Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 92 Middle East and Africa Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 93 GCC Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 94 GCC Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 95 GCC Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 96 GCC Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 97 Africa Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 98 Africa Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 99 Africa Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 100 Africa Bacteriophage Market By Administration Route, 2020-2030, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Bacteriophage Market By Product, 2020-2030, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Bacteriophage Market By Application, 2020-2030, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Bacteriophage Market By Bacteria, 2020-2030, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Bacteriophage Market By Administration Route, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Bacteriophage Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Bacteriophage Market: Quality Assurance
  • FIG. 5 Global Bacteriophage Market, By Product, 2021
  • FIG. 6 Global Bacteriophage Market, By Application, 2021
  • FIG. 7 Global Bacteriophage Market, By Bacteria, 2021
  • FIG. 8 Global Bacteriophage Market, By Administration Route, 2021
  • FIG. 9 Global Bacteriophage Market, By Geography, 2021
  • FIG. 10 Market Geographical Opportunity Matrix - Global Bacteriophage Market, 2021
  • FIG. 11 Market Positioning of Key Bacteriophage Market Players, 2021
  • FIG. 12 Global Bacteriophage Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 13 Porters Five Force Model - Current, Midterm and Long Term Perspective
  • FIG. 14 See Saw Analysis
  • FIG. 15 PETEL Analysis
  • FIG. 16 Key Buying Criteria: Current and Long-Term Perspective
  • FIG. 17 Global Bacteriophage Market, Scenario Analysis, 2020 to 2030 (US$ Million)
  • FIG. 18 Heptalysis Analysis: Global Bacteriophage Market
  • FIG. 19 Five Whys Analysis
  • FIG. 20 Global Bacteriophage Market, By Product, 2021 Vs 2030, %
  • FIG. 21 Global Bacteriophage Market, By Application, 2021 Vs 2030, %
  • FIG. 22 Global Bacteriophage Market, By Bacteria, 2021 Vs 2030, %
  • FIG. 23 Global Bacteriophage Market, By Administration Route, 2021 Vs 2030, %
  • FIG. 24 U.S. Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 25 Canada Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 26 Rest of North America Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 27 UK Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 28 Germany Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 29 Spain Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 30 Italy Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 31 France Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 32 Rest of Europe Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 33 China Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 34 Japan Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 35 India Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 36 Australia Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 37 South Korea Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 38 Rest of Asia Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 39 Brazil Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 40 Mexico Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 41 Rest of Latin America Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 42 GCC Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 43 Africa Bacteriophage Market (US$ Million), 2020 - 2030
  • FIG. 44 Rest of Middle East and Africa Bacteriophage Market (US$ Million), 2020 - 2030
目次
Product Code: 138364-08-22

The global bacteriophage market is expected to grow at compound annual growth rate (CAGR) of 4.5%. Raise in incidence of antimicrobial resistance will lead to growth in Bacteriophage market in the upcoming years. According to Centers for disease control & prevention CDC at least 23,000 of people in the United States & around 33,000 people in Europe die due to antibiotic resistant infections. With increasing inpatient care there has been a rise in the adoption of bacteriophage in phage research centers, along with bacteriophage supplements. Bacteriophage is also known as phage therapy and it needs viruses for the medication of bacterial infections. Bacterial viruses are called phages or bacteriophages. Bacteriophages are supposed to be natural antagonists of bacteria and are found in soil, water, sewage & other places where bacterias are exposed. With the recent advances in technology, particularly the ability to elucidate genome sequences of bacterial hosts, there has been a renewed interest in phages. Traditionally, phages have been considered as a nuisance in the industrial processes that depend on bacterial fermentation. Since the discovery of bacteriophages, many researchers have considered their potential as therapeutic agents. After the World War II, when antibiotics were discovered, the natural potential of bacteriophages received little attention and was considered only as a research tool. Bacteriophages have significantly contributed in the field of biotechnology and molecular biology and are still playing an important role. Today, their potential to be used as phage display systems, antibacterials, vehicles for vaccines and biocontrol agents, and the attention towards bacteriophages is rekindled.

Increasing R&D is Expected to Multiply Revenues

The Bacteriophage market is expected to grow at a significant rate due to rising manufacturing of antibiotic resistant infection, rising research activities for development of therapies, increasing adoption of growth strategies such as acquisitions, and collaborations by market players. Emergence of e-Commerce is increasing the share of pharmaceuticals companies. Most companies are focusing on setting up online stores of Bacteriophage preparations to make phages and phage therapy available across the world. The Bacteriophage must be treated with safety precautions & there is no data related to these methods. . Increasing government funding to support phage therapy manufacturers in developing an innovative approach to decrease antimicrobial-resistant infection cases is anticipated to boost market growth.

"Food & Beverages Display Highest Share by Application in Bacteriophage Market" At present food & beverages occupy the largest revenue share in the global bacteriophage market. Bacteriophages find the widest application in food biocontrol and present as a natural and green method that uses lytic bacteriophages derived from the environment to target pathogenic bacteria. Since the initial conception of the use of bacteriophages on foods, additional research are also being conducted for using bacteriophage to target pathogenic bacteria in ready to eat meals, fresh fruits, dairy products and vegetables. This has led to increase in approved products containing bacteriophages for food safety applications. Clinical applications of bacteriophages will witness the fastest market growth during the forecast period. Increased use of bacteriophages in diagnostics, phage display technology and potential use in drug discovery and development are the main attributes to the fast growth of this segment.

North America Remains the Market Leader

Growing failure of antibiotic treatment to fight against infections such as multi-drug resistant Staphylococcus aureus has renewed interest in bacteriophage therapy in countries such as Georgia Poland Russia etc. The U.S. bacteriophage market is expanding due to rising prevalence of antibiotic resistance and increasing demand for an alternative to antibiotics in the country. However, lack of regulatory approval by USFDA for therapeutic bacteriophages is somewhat hampering market expansion in the U.S.

North America held the largest regional market share for bacteriophage market in 2020. Strong desire to overcome the burden of antibiotic-resistant infections, strongly established research infrastructure, and existence of potential pipeline for phage therapy are the key attributes of North America market. Europe is the second largest market for bacteriophage on the grounds of wide application of bacteriophage in food and environmental fields and stable presence of phage therapy in the region. Asia Pacific will witness the fastest progress in the global market. Rapidly evolving biotechnology infrastructure, evolving agriculture practices, and equally supportive government initiatives contribute to the rapid growth of Asia Pacific market.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Bacteriophage market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Bacteriophage market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • dsDNA Bacteriophage
  • ssDNA Bacteriophage
  • ssRNA BActeriophage

Application

  • Food & Beverages
  • Phage Display
  • Phage Therapy
  • Environmental Application
  • Veterinary
  • Diagnostic
  • Antimicrobial Drug Discovery

Bacteria

  • Salmonella Bacteriophage
  • Streptococcus Bacteriophage
  • Escherichia Coli
  • Streptococcus & Pseudomonas Bacteriophage

Administration Route

  • Topical
  • Intravenous
  • Trans nasal
  • Oral & trans rectal

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Bacteriophage market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Bacteriophage market?
  • Which is the largest regional market for Bacteriophage market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Bacteriophage market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Bacteriophage market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Bacteriophage Market
  • 2.2. Global Bacteriophage Market, By Product, 2021 (US$ Million)
  • 2.3. Global Bacteriophage Market, By Application, 2021 (US$ Million)
  • 2.4. Global Bacteriophage Market, By Bacteria, 2021 (US$ Million)
  • 2.5. Global Bacteriophage Market, By Administration Route, 2021 (US$ Million)
  • 2.6. Global Bacteriophage Market, By Geography, 2021 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2021
  • 2.8. Key Buying Criteria
  • 2.9. Key Case Reports
  • 2.10. Scenario Analysis
    • 2.10.1. Optimistic estimates and analysis
    • 2.10.2. Realistic estimates and analysis
    • 2.10.3. Pessimistic estimates and analysis
  • 2.11. Market Profiling
  • 2.12. Sales and Marketing Plan
  • 2.13. Top Market Conclusions
  • 2.14. Strategic Recommendations

3. Bacteriophage Market: Competitive Analysis

  • 3.1. Market Positioning of Key Bacteriophage Market Vendors
  • 3.2. Strategies Adopted by Bacteriophage Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Bacteriophage Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Bacteriophage Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape
  • 4.8. Heptalysis Analysis
  • 4.9. Critical Investigation of Business Problems Through Five Whys Root Cause Analysis & Relevant Solutions

5. Bacteriophage Market: By Product, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. dsDNA Bacteriophage
    • 5.3.2. ssDNA Bacteriophage
    • 5.3.3. ssRNA BActeriophage

6. Bacteriophage Market: By Application, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Food & Beverages
    • 6.3.2. Phage Display
    • 6.3.3. Phage Therapy
    • 6.3.4. Environmental Application
    • 6.3.5. Veterinary
    • 6.3.6. Diagnostic
    • 6.3.7. Antimicrobial Drug Discovery

7. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 7.3. Market Segmentation
    • 7.3.1. Salmonella Bacteriophage
    • 7.3.2. Streptococcus Bacteriophage
    • 7.3.3. Escherichia Coli
    • 7.3.4. Streptococcus & Pseudomonas Bacteriophage

8. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 8.3. Market Segmentation
    • 8.3.1. Topical
    • 8.3.2. Intravenous
    • 8.3.3. Trans nasal
    • 8.3.4. Oral & trans rectal

9. Geographic Analysis

  • 9.1. Market Overview
  • 9.2.Macro Factors versus Market Impact: Dashboard, 2021
  • 9.3. Porters Five Force Model Across Geography: Dashboard, 2021
  • 9.4. Impact of PESTEL factors Across Geography: Dashboard, 2021

10. North America Bacteriophage Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Bacteriophage Market: By Product, 2020-2030, USD (Million)
  • 10.3. Bacteriophage Market: By Application, 2020-2030, USD (Million)
  • 10.4. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
  • 10.5. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
  • 10.6.Bacteriophage Market: By Region, 2020-2030, USD (Million)
    • 10.6.1.North America
      • 10.6.1.1. U.S.
        • 10.6.1.1.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 10.6.1.1.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 10.6.1.1.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 10.6.1.1.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 10.6.1.2. Canada
        • 10.6.1.2.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 10.6.1.2.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 10.6.1.2.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 10.6.1.2.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 10.6.1.3. Rest of North America
        • 10.6.1.3.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 10.6.1.3.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 10.6.1.3.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 10.6.1.3.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)

11. UK and European Union Bacteriophage Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Bacteriophage Market: By Product, 2020-2030, USD (Million)
  • 11.3. Bacteriophage Market: By Application, 2020-2030, USD (Million)
  • 11.4. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
  • 11.5. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
  • 11.6.Bacteriophage Market: By Region, 2020-2030, USD (Million)
    • 11.6.1.UK and European Union
      • 11.6.1.1. UK
        • 11.6.1.1.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 11.6.1.1.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 11.6.1.1.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 11.6.1.1.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 11.6.1.2. Germany
        • 11.6.1.2.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 11.6.1.2.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 11.6.1.2.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 11.6.1.2.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 11.6.1.3. Spain
        • 11.6.1.3.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 11.6.1.3.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 11.6.1.3.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 11.6.1.3.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 11.6.1.4. Italy
        • 11.6.1.4.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 11.6.1.4.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 11.6.1.4.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 11.6.1.4.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 11.6.1.5. France
        • 11.6.1.5.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 11.6.1.5.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 11.6.1.5.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 11.6.1.5.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 11.6.1.6. Rest of Europe
        • 11.6.1.6.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 11.6.1.6.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 11.6.1.6.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 11.6.1.6.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)

12. Asia Pacific Bacteriophage Market, 2020-2030, USD (Million)

  • 12.1. Market Overview
  • 12.2. Bacteriophage Market: By Product, 2020-2030, USD (Million)
  • 12.3. Bacteriophage Market: By Application, 2020-2030, USD (Million)
  • 12.4. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
  • 12.5. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
  • 12.6.Bacteriophage Market: By Region, 2020-2030, USD (Million)
    • 12.6.1.Asia Pacific
      • 12.6.1.1. China
        • 12.6.1.1.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 12.6.1.1.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 12.6.1.1.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 12.6.1.1.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 12.6.1.2. Japan
        • 12.6.1.2.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 12.6.1.2.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 12.6.1.2.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 12.6.1.2.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 12.6.1.3. India
        • 12.6.1.3.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 12.6.1.3.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 12.6.1.3.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 12.6.1.3.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 12.6.1.4. Australia
        • 12.6.1.4.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 12.6.1.4.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 12.6.1.4.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 12.6.1.4.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 12.6.1.5. South Korea
        • 12.6.1.5.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 12.6.1.5.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 12.6.1.5.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 12.6.1.5.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 12.6.1.6. Rest of Asia Pacific
        • 12.6.1.6.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 12.6.1.6.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 12.6.1.6.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 12.6.1.6.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)

13. Latin America Bacteriophage Market, 2020-2030, USD (Million)

  • 13.1. Market Overview
  • 13.2. Bacteriophage Market: By Product, 2020-2030, USD (Million)
  • 13.3. Bacteriophage Market: By Application, 2020-2030, USD (Million)
  • 13.4. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
  • 13.5. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
  • 13.6.Bacteriophage Market: By Region, 2020-2030, USD (Million)
    • 13.6.1.Latin America
      • 13.6.1.1. Brazil
        • 13.6.1.1.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 13.6.1.1.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 13.6.1.1.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 13.6.1.1.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 13.6.1.2. Mexico
        • 13.6.1.2.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 13.6.1.2.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 13.6.1.2.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 13.6.1.2.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 13.6.1.3. Rest of Latin America
        • 13.6.1.3.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 13.6.1.3.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 13.6.1.3.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 13.6.1.3.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)

14. Middle East and Africa Bacteriophage Market, 2020-2030, USD (Million)

  • 14.1. Market Overview
  • 14.2. Bacteriophage Market: By Product, 2020-2030, USD (Million)
  • 14.3. Bacteriophage Market: By Application, 2020-2030, USD (Million)
  • 14.4. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
  • 14.5. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
  • 14.6.Bacteriophage Market: By Region, 2020-2030, USD (Million)
    • 14.6.1.Middle East and Africa
      • 14.6.1.1. GCC
        • 14.6.1.1.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 14.6.1.1.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 14.6.1.1.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 14.6.1.1.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 14.6.1.2. Africa
        • 14.6.1.2.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 14.6.1.2.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 14.6.1.2.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 14.6.1.2.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)
      • 14.6.1.3. Rest of Middle East and Africa
        • 14.6.1.3.1. Bacteriophage Market: By Product, 2020-2030, USD (Million)
        • 14.6.1.3.2. Bacteriophage Market: By Application, 2020-2030, USD (Million)
        • 14.6.1.3.3. Bacteriophage Market: By Bacteria, 2020-2030, USD (Million)
        • 14.6.1.3.4. Bacteriophage Market: By Administration Route, 2020-2030, USD (Million)

15. Company Profile

  • 15.1. AmpliPhi Biosciences Corporation
    • 15.1.1. Company Overview
    • 15.1.2. Financial Performance
    • 15.1.3. Product Portfolio
    • 15.1.4. Strategic Initiatives
  • 15.2. Phage Biotech Ltd.
    • 15.2.1. Company Overview
    • 15.2.2. Financial Performance
    • 15.2.3. Product Portfolio
    • 15.2.4. Strategic Initiatives
  • 15.3. EnBiotix
    • 15.3.1. Company Overview
    • 15.3.2. Financial Performance
    • 15.3.3. Product Portfolio
    • 15.3.4. Strategic Initiatives
  • 15.4. Fixed-Phage Limited
    • 15.4.1. Company Overview
    • 15.4.2. Financial Performance
    • 15.4.3. Product Portfolio
    • 15.4.4. Strategic Initiatives
  • 15.5. InnoPhage, Ltd.
    • 15.5.1. Company Overview
    • 15.5.2. Financial Performance
    • 15.5.3. Product Portfolio
    • 15.5.4. Strategic Initiatives
  • 15.6. PHERECYDES PHARMA
    • 15.6.1. Company Overview
    • 15.6.2. Financial Performance
    • 15.6.3. Product Portfolio
    • 15.6.4. Strategic Initiatives
  • 15.7. TechnoPhage SA
    • 15.7.1. Company Overview
    • 15.7.2. Financial Performance
    • 15.7.3. Product Portfolio
    • 15.7.4. Strategic Initiatives
  • 15.8. Federal State Scientific-Industrial Company MICROGEN
    • 15.8.1. Company Overview
    • 15.8.2. Financial Performance
    • 15.8.3. Product Portfolio
    • 15.8.4. Strategic Initiatives
  • 15.9. Phage Therapy Center
    • 15.9.1. Company Overview
    • 15.9.2. Financial Performance
    • 15.9.3. Product Portfolio
    • 15.9.4. Strategic Initiatives
  • 15.10. VersatileBio
    • 15.10.1. Company Overview
    • 15.10.2. Financial Performance
    • 15.10.3. Product Portfolio
    • 15.10.4. Strategic Initiatives